SAT-262 RATIONALE AND DESIGN OF 'CARDINAL': A PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

Autor:	G. Block, L. Inker A., M. Chin P., A. Goldsberry, C. Meyer J., M. O'Grady, A. Rastogi, S. Sprague M., A. Silva L., P. Pergola E.
Rok vydání:	2019
Předmět:	medicine.medical_specialty Nephrology business.industry Urology Medicine In patient Bardoxolone methyl Alport syndrome business medicine.disease
Zdroj:	Kidney International Reports. 4:S116
ISSN:	2468-0249
DOI:	10.1016/j.ekir.2019.05.299
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f81bbbd788da792a295e241af7aa3cb2 https://doi.org/10.1016/j.ekir.2019.05.299 Zobrazit plný text záznamu